Details of the Drug Reposition

General Information of This Drug (ID: DMIJNLG)

Drug Name
Semapimod   DMIJNLG
Synonyms CPSI-2364; Semapimod (oral); Semapimod (oral), Cytokine PharmaSciences
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Autoimmune diabetes DISW6UF1 5A10 Phase 2 [1]
Inflammatory bowel disease DISGN23E DD72 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00038766) CNI-1493 for Treatment of Moderate to Severe Crohn's Disease. U.S. National Institutes of Health.